Survival Analysis of 159 Patients With Advanced Non-Small-Cell Lung Cancer Resistant to First-Generation Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor

BACKGROUND: Epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) have limited or no response in some certain patients of non-small-cell lung cancer (NSCLC). However, real-world survival analyses comparing clinical data and EGFR-plasma mutation are still lacking. METHODS: In total,...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Aimin, Li, Kun, Zheng, Hua, Rao, Haitao, Zhang, Tongmei, Li, Baolan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10291855/
https://www.ncbi.nlm.nih.gov/pubmed/37378392
http://dx.doi.org/10.1177/11795549231176398

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10291855/
https://www.ncbi.nlm.nih.gov/pubmed/37378392
http://dx.doi.org/10.1177/11795549231176398

Ejemplares similares